Polycystic kidney diseases (PKD) are characterized by excessive proliferation of renal tubular epithelial cells, development of fluid-filled cysts, and progressive renal insufficiency. cAMP inhibits proliferation of normal renal tubular epithelial cells but stimulates proliferation of renal tubular epithelial cells derived from patients with PKD. Madin-Darby canine kidney (MDCK) epithelial cells, which are widely used as an in vitro model of cystogenesis, also proliferate in response to cAMP. Intracellular cAMP levels are tightly regulated by phosphodiesterases (PDE). Isoform-specific PDE inhibitors have been developed as therapeutic agents to regulate signaling pathways directed by cAMP. In other renal cell types, we have previously demonstrated that cAMP is hydrolyzed by PDE3 and PDE4, but only PDE3 inhibitors suppress proliferation by inhibiting Raf-1 activity (Cheng J, Thompson MA, Walker HJ, Gray CE, Diaz Encarnacion MM, Warner GM, Grande JP. Am J Physiol Renal Physiol 287:F940-F953, 2004.) A potential role for PDE isoform(s) in cAMP-mediated proliferation of MDCK cells has not previously been established. Similar to what we have previously found in several other renal cell types, cAMP hydrolysis in MDCK cells is directed primarily by PDE4 (85% of total activity) and PDE3 (15% of total activity). PDE4 inhibitors are more effective than PDE3 inhibitors in increasing intracellular cAMP levels in MDCK cells. However, only PDE3 inhibitors, and not PDE4 inhibitors, stimulate mitogenesis of MDCK cells. PDE3 but not PDE4 inhibitors activate B-Raf but not Raf-1, as assessed by an in vitro kinase assay. PDE3 but not PDE4 inhibitors activate the ERK pathway and activate cyclins D and E, as assessed by histone H1 kinase assay. We conclude that mitogenesis of MDCK cells is regulated by a functionally compartmentalized intracellular cAMP pool directed by PDE3. Pharmacologic agents that stimulate PDE3 activity may provide the basis for new therapies directed toward reducing cystogenesis in patients with PKD.
YamaguchiT, NagaoS, KasaharaM, TakahashiH, GranthamJ.Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease. Am J Kidney Dis20: 703–709, 1997.
5.
GranthamJJ. Renal cell proliferation and the two faces of cyclic adenosine monophosphate. J Lab Clin Med130: 459–460, 1997.
6.
Mangoo-KarimR, UchicM, LecheneC, GranthamJ.Renal epithelial cyst formation and enlargement in vitro: dependence on cAMP. Proc Nad Acad Sci U S A86: 6007–6011, 1989.
7.
McCaffreyTA, DuB, ConsigliS, SzaboP, BrayPJ, HartnerL, WekslerBB, SanbornTA, BergmanG, BushHL. Genomic instability in the type II TGF-β1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest100: 2182–2188, 1997.
8.
GravesLM, BornfeldtKE, SidhuJS, ArgastGM, RainesEW, RossR, LeslieCC, KrebsEG. Platelet-derived growth factor stimulates protein-kinase A through a mitogen-activated protein kinase-dependent pathway in human arterial smooth muscle cells. J Biol Chem271: 505–511, 1996.
9.
ErhardtP, TroppmairJ, RappR, CooperG.Differential regulation of Raf-1 and B-Raf and Ras-dependent activation of mitogen-activated protein kinase by cyclic AMP in PC12 cells. Mol Cell Biol15: 5524–5530, 1995.
ChengJ, ThompsonMA, WalkerHJ, GrayCE, Diaz EncarnacionMM, WarnerGM, GrandeJP. Differential regulation of mesangial cell mitogenesis by cAMP phosphodiesterase isozymes 3 and 4. Am J Physiol Renal Physiol287:F940–F953, 2004.
18.
GrandeJP, JonesML, SwensonCL, KillenPD, WarrenJS. Lipopolysaccharide induces monocyte chemoattractant protein production by rat mesangial cells. J Lab Clin Med124: 112–117, 1994.
19.
ChiniCCS, ChiniEN, WilliamsJM, MatousovicK, DousaTP. Formation of reactive oxygen metabolites in glomeruli is suppressed by inhibition of cAMP phosphodiesterase isozyme type IV. Kidney Int46: 28–36, 1994.
20.
YamakiM, McIntyreS, RassierME, SchwartzJH, DousaTP. Cyclic 3',5'-nucleotide diesterases in dynamics of cAMP and cGMP in rat collecting duct cells. Am J Physiol262:F957–F964, 1992.
StorkPJ, SchmittJM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol12: 258–266, 2002.
27.
ChiniE, ChiniC, BollingerC, JougasakiM, GrandeJ, BurnettJ, DousaT.Cytoprotective effects of adrenomedullin in glomerular cell injury: central role of cAMP signaling pathway. Kidney Int52: 917–925, 1997.
28.
MatousovicK, GrandeJP, ChiniCCS, ChiniEN, DousaTP. Inhibitors of cyclic nucleotide phosphodiesterase isozymes type-III and type-IV suppress mitogenesis of rat mesangial cells. J Clin Invest96: 401–410, 1995.
29.
HidaM, FujitaH, IshikuraK, OmoriS, HoshiyaM, AwazuM.Eicosapentaenoic acid inhibits PDGF-induced mitogenesis and cyclin D1 expression via TGF-beta in mesangial cells. J Cell Physiol196: 293–300, 2003.
30.
Mangoo-KarimR, UchicM, GrantM, ShumateW, CalvetJ, ParkC, GranthamJ.Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J3: 2629–2632, 1989.
31.
BelibiFA, WallaceDP, YamaguchiT, ChristensenM, ReifG, GranthamJJ. The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol13: 2723–2729, 2002.
32.
YamaguchiT, PellingJ, RamaswamyN, EpplerJ, WallaceD, NagaoS, RomeL, SullivanL, GranthamJ.Cyclic AMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int57: 1460–1471, 2000.
33.
GravesLM, BornfeldtKE, ArgastGM, KrebsEG, KongX, LinTA, LawrenceJCJr.cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells. Proc Natl Acad Sci U S A92: 7222–7226, 1995.
34.
JonesML, WarrenJS. Monocyte chemoattractant protein 1 in a rat model of pulmonary granulomatosis. Lab Invest66: 498–503, 1992.
35.
WolfG, NeilsonEG. Molecular mechanisms of tubulointerstitial hypertrophy and hyperplasia. Kidney Int39: 401–420, 1991.
36.
EkblomP, WellerA.Ontogeny of tubulointerstitial cells. Kidney Int39: 394–400, 1991.
37.
SantiagoA, SatrianoJ, DeCandidoS, HolthoferH, SchreiberR, UnkelessJ, SchlondorffD.A specific Fc-gamma receptor on cultured rat mesangial cells. J Immunol143: 2575–2582, 1989.
38.
LeeTH, ChuangLY, HungWC. Induction of p21WAF1 expression via Sp1-binding sites by tamoxifen in estrogen receptor-negative lung cancer cells. Oncogene19: 3766–3773, 2000.
39.
van OirschotBA, StahlM, LensSM, MedemaRH. Protein kinase A regulates expression of p27(kip1) and cyclin D3 to suppress proliferation of leukemic T cell lines. J Biol Chem276: 33854–33860, 2001.
40.
L'allemainG, LavoieJN, RivardN, BaldinV, PouyssegurJ.Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts. Oncogene14: 1981–1990, 1997.
41.
KitagawaM, HigashiH, JungH, Suzuki-TakahashiI, IkedaM, TamaiK, KatoJ, SegawaK, YoshidaE, NishimuraS, TayaY.The consensus motif for phosphorylation by cyclin D1-cdk4 is different from that for phosphorylation by cyclin A/E-cdk2. EMBO J15: 7060–7069, 1996.
42.
LundbergA, WeinbergR.Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol Cell Biol18: 753–761, 1998.
43.
ShanklandSJ, HugoC, CoatsSR, NangakuM, PichlerRH, GordonKL, PippinJ, RobertsJM, CouserWG, JohnsonRJ. Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int50: 1230–1239, 1996.
44.
ShanklandSJ, PippinJ, FlanaganM, CoatsSR, NangakuM, GordonKL, RobertsJM, CouserWG, JohnsonRJ. Mesangial cell proliferation mediated by PDGF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kipl. Kidney Int51: 1088–1099, 1997.
